Skip to content
Back to announcement

20250708_KAEF_Pemanggilan RUPS_31913041_lamp2.pdf

RUPS notice Text extracted KAEF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
                       REVISION TO THE SUMMON OF
        ANNUAL GENERAL MEETING OF SHAREHOLDERS FOR FISCAL YEAR 2024
                           PT KIMIA FARMA TBK


Referring to the Summon of the Annual General Meeting of Shareholders of PT Kimia Farma
Tbk (the “Company”) for Fiscal Year 2024, which was published on the Indonesia Stock
Exchange website (www.idx.co.id, eASY.KSEI via https://easy.ksei.co.id and the Company’s
official website www.kimiafarma.co.id on July 7, 2025, the Company hereby inform its
shareholders that the AGMS of PT Kimia Farma Tbk for Fiscal Year 2024 (the “MEETING”),
previously scheduled for July 29, 2025, has been rescheduled to:

 Day and Date : Wednesday, July 30, 2025
 Time         : 16.00 WIB until completion
 Link to Join : Access the Electronic General Meeting System KSEI (eASY.KSEI) through
 the    AGMS    the link https://akses.ksei.co.id provided by KSEI.


In accordance with Regulations No. 15/POJK.04/2020 and No. 16/POJK.04/2020 concerning
the electronic conduct of MEETING, the Notary, relevant Professionals, and Supporting
Institutions will coordinate the electronic implementation of the MEETING at Indonesia
Health Learning Institute, located at Jl. Cipinang Cimpedak I No. 36, East Jakarta.

With MEETING Agendas as follows:
   1. Board of Directors’ report on the Delay of the Annual General Meeting of
      Shareholders for the Fiscal Year 2024.
   2. Approval of the Company's Annual Report and Ratification of the Company's
      Consolidated Financial Statements of the Fiscal Year 2024, Approval of the Board
      of Commissioners Oversight Report of the Fiscal Year 2024, including Ratification
      of the Re-issue and Restatement of the Financial Statements of the Fiscal Year
      2023, and Ratification of the Implementation Report of the Micro and Small
      Business Funding Programme of the Fiscal Year 2024, as well as Granting full
      release and discharge (volledig acquit et de charge) to the Board of Directors for
      the Company's Management Actions and the Board of Commissioners for the
      Company's Supervisory Actions that have been carried out during the Fiscal Year
      2024 and for the Re-issue and Restatement of the Consolidated Financial
      Statements for the Fiscal Year 2023.
   3. Approval of the Allocation of the Company's Net Profit for the Fiscal Year 2024.
   4. Determination of Salary/Honorarium along with Facilities and Allowances for Fiscal
      Year 2025, as well as Tantiem/Performance Incentives/Special Incentives for the
      Performance of Fiscal Year 2024 for the Board of Directors and Board of
      Commissioners of the Company.
Page 2
   5. Approval of the Appointment of a Public Accountant and/or Public Accounting Firm
      (KAP) to audit the Company’s Financial Statements for Fiscal Year 2025 as well as
      the Financial Statements of the Micro and Small Business Funding Program (PUMK)
      for Fiscal Year 2025.
   6. Report on the Implementation of the Mandatory Convertible Bonds (OWK)
      Conversion into Shares for the Purpose of Increasing the Company's Capital, and
      Approval to Grant Authority to the Company's Board of Commissioners to
      Determine the Amount of Issued and Paid-up Capital Increase.
   7. Change in the Composition of the Company’s Management.

The date of the Shareholders Register (Recording Date), which contains the list of the
Company’s shareholders entitled to attend the MEETING, as well as all provisions and
procedures previously announced in the prior Summon, remain valid and unchanged.

In accordance with the Financial Services Authority Regulation Number 15/POJK.04/2020
concerning the Planning and Organization of General Meetings of Shareholders of Public
Companies and the provisions of the Company's Articles of Association, this revision to the
Summon of the MEETING is announced through the Indonesia Stock Exchange website,
eASY.KSEI via https://akses.ksei.co.id, and the Company’s website.

This, this Revision to the Summon of the MEETING is hereby conveyed for the attention and
understanding of the Company’s shareholders.



                                   Jakarta, July 8, 2025
                                  The Board of Directors
                                   PT Kimia Farma Tbk

File

File Open PDF
Source IDX
Size0.12 MB
Published8 Jul 2025
Pages2
Characters4,293
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 3 people and organisations named in the text · linked when the evidence is strong

linked org KIMIA FARMA TBK p.1 ×11
unresolved org Indonesia Stock Exchange p.1 ×2
unresolved org Financial Services Authority p.2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result